Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debarshi Roy

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Health Science Reports|August 13, 2021
Health disparity and COVID-19-A retrospective analysisSanjay Sarkar, Archie Taylor, Pratik Dutta, et al.
Biochemical and Biophysical Research Communications|January 13, 2022
Multi-component redox system for selective and potent antineoplastic activity towards ovarian cancer cellsDebarshi Roy, Brenita Jenkins, Aqeeb Ali, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Debarshi Roy, Ling Jin, et al.
The Journal of Biological Chemistry|April 17, 2013
Glucosylceramide transferase activity is critical for encystation and viable cyst production by an intestinal protozoan, Giardia lambliaTavis L Mendez, Atasi De Chatterjee, Trevor T Duarte, et al.
International Journal of Cancer|September 19, 2018
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancersSusmita Mondal, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesBoris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
JTO Clinical and Research Reports|December 30, 2024
Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for MesotheliomaKaushal Parikh, Faye R Harris, Giannoula Karagouga, et al.
Cancer Research|October 16, 2021
Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian CancerUpasana Ray, Deok-Beom Jung, Ling Jin, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Health Science Reports|August 13, 2021
Health disparity and COVID-19-A retrospective analysisSanjay Sarkar, Archie Taylor, Pratik Dutta, et al.
Biochemical and Biophysical Research Communications|January 13, 2022
Multi-component redox system for selective and potent antineoplastic activity towards ovarian cancer cellsDebarshi Roy, Brenita Jenkins, Aqeeb Ali, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Debarshi Roy, Ling Jin, et al.
The Journal of Biological Chemistry|April 17, 2013
Glucosylceramide transferase activity is critical for encystation and viable cyst production by an intestinal protozoan, Giardia lambliaTavis L Mendez, Atasi De Chatterjee, Trevor T Duarte, et al.
International Journal of Cancer|September 19, 2018
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancersSusmita Mondal, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesBoris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
JTO Clinical and Research Reports|December 30, 2024
Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for MesotheliomaKaushal Parikh, Faye R Harris, Giannoula Karagouga, et al.
Cancer Research|October 16, 2021
Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian CancerUpasana Ray, Deok-Beom Jung, Ling Jin, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Pageof 4